Trending Now
NASDAQ inches higher as VIX plummets
Markets continue their float higher as selling pressure seems to be waning. Volatility is finally starting to make a meaningful contraction, with...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Amicus Therapeutics (NASDAQ: FOLD) Granted Approval From the European Commission for...
Amicus Therapeutics (NASDAQ: FOLD) is a patient-focused worldwide biotech corporation that focuses on delivering, developing, and discovering novel medication products for rare diseases. The company...
MAKE IT MODERN
LATEST REVIEWS
Senti Biosciences (SNTI) Secures $8 Million Grant to Advance Groundbreaking Cancer...
In a significant advancement for cancer therapy, Senti Biosciences, Inc. (NASDAQ: SNTI), commonly known as Senti Bio, has received an $8...
MAKE IT MODERN
PERFORMANCE TRAINING
Sigilon Therapeutics Inc (NASDAQ: SGTX) Phase 1/22 Study of SIG-OO1 Placed On Hold
Sigilon Therapeutics Inc (NASDAQ: SGTX), a biotechnology firm that develops functional cures for chronic diseases via its Shielded Living Therapeutics, has recently placed its...
CMS Grants NTAP For Nabriva Therapeutics PLC (NASDAQ:NBRV)’s XENLETA For Injection
CMS (Centers for Medicare & Medicaid Services) issued NTAP (new technology add on payment) for Nabriva Therapeutics PLC (NASDAQ:NBRV)’s XENLETA. NTAP is used for...
Minerva Neurosciences Inc (NASDAQ: NERV) Submits New Drug Application for Roluperidone In Treating Negative...
Minerva Neurosciences Inc (NASDAQ: NERV) has announced the submission of a New Drug Application to the US FDA for roluperidone in treating negative schizophrenia...
Pharmacy Services Back on the Radar (MDRX, WBA, RXMD, CVS)
The big step from here is an improvement and normalization in terms of our relationship with healthcare. But, because of what we have all...
This is where TSLA stock is heading next and may not be good news...
Tesla Inc (NASDAQ:TSLA) lost quite a bit of steam after the investor day. The market was eagerly waiting for TSLA to unveil...
MAKE IT MODERN
